These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 20531475)
1. [Antibodies to synthetic peptides for the detection of survivin in tumor tissues]. Akhidova EV; Volkova TD; Koroev DO; Kim IaS; Filatova MP; Vladimirova NM; Karmakova TA; Zavalishina LE; Andreeva IuIu; Vol'pina OM Bioorg Khim; 2010; 36(2):178-86. PubMed ID: 20531475 [TBL] [Abstract][Full Text] [Related]
2. [Antitumor immunotherapy with the use of synthetic fragments of survivin]. Volkova TD; Koroev DO; Titova MA; Oboznaia MB; Filatova MP; Pankratov AA; Morozova NB; Zolotavkina IuB; Iakubovskaia RI; Vol'pina OM Bioorg Khim; 2008; 34(4):457-63. PubMed ID: 18695717 [TBL] [Abstract][Full Text] [Related]
3. [Antibodies for detection of E/K amino acid substitution in 129 position of the survivin sequence]. Volkova TD; Askarova EV; Koroev DO; Kamynina AV; Filatova MP; Iakupov IIu; Vol'pina OM Bioorg Khim; 2014; 40(4):443-50. PubMed ID: 25898754 [TBL] [Abstract][Full Text] [Related]
4. A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins. Idenoue S; Hirohashi Y; Torigoe T; Sato Y; Tamura Y; Hariu H; Yamamoto M; Kurotaki T; Tsuruma T; Asanuma H; Kanaseki T; Ikeda H; Kashiwagi K; Okazaki M; Sasaki K; Sato T; Ohmura T; Hata F; Yamaguchi K; Hirata K; Sato N Clin Cancer Res; 2005 Feb; 11(4):1474-82. PubMed ID: 15746049 [TBL] [Abstract][Full Text] [Related]
5. Survivin: a promising biomarker in breast carcinoma. Adamkov M; Halasova E; Kajo K; Machalekova K; Vybohova D; Varga I; Rajcany J Neoplasma; 2010; 57(6):572-7. PubMed ID: 20845996 [TBL] [Abstract][Full Text] [Related]
6. An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Hirohashi Y; Torigoe T; Maeda A; Nabeta Y; Kamiguchi K; Sato T; Yoda J; Ikeda H; Hirata K; Yamanaka N; Sato N Clin Cancer Res; 2002 Jun; 8(6):1731-9. PubMed ID: 12060610 [TBL] [Abstract][Full Text] [Related]
7. The expression and significance of survivin mRNA in urinary bladder carcinomas. Wang H; Xi X; Kong X; Huang G; Ge G J Cancer Res Clin Oncol; 2004 Aug; 130(8):487-90. PubMed ID: 15138808 [TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer. Tsuruma T; Iwayama Y; Ohmura T; Katsuramaki T; Hata F; Furuhata T; Yamaguchi K; Kimura Y; Torigoe T; Toyota N; Yagihashi A; Hirohashi Y; Asanuma H; Shimozawa K; Okazaki M; Mizushima Y; Nomura N; Sato N; Hirata K J Transl Med; 2008 May; 6():24. PubMed ID: 18471305 [TBL] [Abstract][Full Text] [Related]
9. Survivin mRNA copy number in bladder washings predicts tumor recurrence in patients with superficial urothelial cell carcinomas. Schultz IJ; Kiemeney LA; Karthaus HF; Witjes JA; Willems JL; Swinkels DW; Gunnewiek JM; de Kok JB Clin Chem; 2004 Aug; 50(8):1425-8. PubMed ID: 15277352 [No Abstract] [Full Text] [Related]
10. [Antibodies against synthetic fragments of the prion protein for the diagnosis of bovine spongiform encephalopathy]. Vol'pina OM; Zhmak MN; Obozhaia MB; Titova MA; Koroev DO; Volkova TD; Egorov AA; Ivanov VT Bioorg Khim; 2001; 27(5):352-8. PubMed ID: 11641909 [TBL] [Abstract][Full Text] [Related]
11. Bladder cancer detection with urinary survivin, an inhibitor of apoptosis. Sharp JD; Hausladen DA; Maher MG; Wheeler MA; Altieri DC; Weiss RM Front Biosci; 2002 Feb; 7():e36-41. PubMed ID: 11815300 [TBL] [Abstract][Full Text] [Related]
12. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781 [TBL] [Abstract][Full Text] [Related]
13. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy. Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519 [TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis. Weikert S; Christoph F; Schrader M; Krause H; Miller K; Müller M Int J Cancer; 2005 Aug; 116(1):100-4. PubMed ID: 15761870 [TBL] [Abstract][Full Text] [Related]
15. [Obtaining of the affinity purified antibodies against survivin for the structure functional study of the protein]. Akhidova EV; Volkova TD; Koroev DO; Yakupov IIu; Kalintseva MV; Zavalishina LE; Kaplun AP; Zharskaia OO; Zatsepina OV; Vol'pina OM Bioorg Khim; 2013; 39(3):326-37. PubMed ID: 24397031 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder. Gonzalez S; Aubert S; Kerdraon O; Haddad O; Fantoni JC; Biserte J; Leroy X Am J Clin Pathol; 2008 Feb; 129(2):232-7. PubMed ID: 18208803 [TBL] [Abstract][Full Text] [Related]
17. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2. Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543 [TBL] [Abstract][Full Text] [Related]
18. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. O'Connor DS; Grossman D; Plescia J; Li F; Zhang H; Villa A; Tognin S; Marchisio PC; Altieri DC Proc Natl Acad Sci U S A; 2000 Nov; 97(24):13103-7. PubMed ID: 11069302 [TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of survivin in breast cancer. Kennedy SM; O'Driscoll L; Purcell R; Fitz-Simons N; McDermott EW; Hill AD; O'Higgins NJ; Parkinson M; Linehan R; Clynes M Br J Cancer; 2003 Apr; 88(7):1077-83. PubMed ID: 12671708 [TBL] [Abstract][Full Text] [Related]
20. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Schmitz M; Diestelkoetter P; Weigle B; Schmachtenberg F; Stevanovic S; Ockert D; Rammensee HG; Rieber EP Cancer Res; 2000 Sep; 60(17):4845-9. PubMed ID: 10987296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]